Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly prospective heart disease study Commentary: Chlamydia pneumoniae infection and ischaemic heart disease

SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION

1988 • 1,989 citations

Chronic infections and coronary heart disease: is there a link?

1997 • 1,225 citations

Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.

1991 • 953 citations

C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

1996 • 869 citations

Classification of occupations

1948 • 818 citations

Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study

1992 • 790 citations

Demonstration of Chlamydia pneumoniae in Atherosclerotic Lesions of Coronary Arteries

1993 • 765 citations

A NewChlamydia psittaciStrain, TWAR, Isolated in Acute Respiratory Tract Infections

1986 • 727 citations

Elevated Chlamydia pneumoniae Antibodies, Cardiovascular Events, and Azithromycin in Male Survivors of Myocardial Infarction

1997 • 726 citations

Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors

1995 • 609 citations

Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study

1997 • 579 citations

Chlamydial Heat Shock Protein 60 Localizes in Human Atheroma and Regulates Macrophage Tumor Necrosis Factor-α and Matrix Metalloproteinase Expression

1998 • 546 citations

Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis

1993 • 528 citations

Isolation of Chlamydia pneumoniae from the Coronary Artery of a Patient with Coronary Atherosclerosis

1996 • 480 citations

Epidemiology and prevention: Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland

1996 • 459 citations

Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease

1992 • 399 citations

Endovascular Presence of Viable Chlamydia pneumoniaeIs a Common Phenomenon in Coronary Artery Disease 11This study was supported in part by the Research Commission of the Medical University of Lübeck (8/96) and the Deutsche Forschungsgemeinschaft (SFB 367/B2), Bonn, Germany.

1998 • 364 citations

Prevalence of dermatophyte onychomycosis in the United Kingdom: Results of an omnibus survey

1992 • 347 citations

Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein.

1989 • 334 citations

Antifungal agents: An overview. Part II

1994 • 322 citations

The Caerphilly and Speedwell Collaborative Heart Disease Studies

1992 • 278 citations

The prevalence of onychomycosis in Finland

2006 • 238 citations

Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men: The Caerphilly and Speedwell Collaborative Heart Disease Studies

1992 • 208 citations

Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis.

1997 • 206 citations

: Risk factors for seropositivity and association with coronary heart disease

1995 • 191 citations

Confirmed Previous Infection With Chlamydia pneumoniae (TWAR) and Its Presence in Early Coronary Atherosclerosis

1998 • 168 citations

Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole

1996 • 159 citations

Caerphilly and Speedwell collaborative heart disease studies. The Caerphilly and Speedwell Collaborative Group.

1984 • 155 citations

Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection

1995 • 144 citations

Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not

1998 • 142 citations

A 12-week treatment for dermatophyte toe onychomycosis terbinafine 250mg/day vs. itraconazole 200mg/day-a double-blind comparative trial

1996 • 131 citations

Acute coronary thrombosis--the role of plaque disruption and its initiation and prevention

1995 • 128 citations

Prevalence of dermatophyte onychomycosis in Spain: a cross-sectional study

2006 • 128 citations

Associations of alcohol consumption with plasma high density lipoprotein cholesterol and its major subfractions: the Caerphilly and Speedwell Collaborative Heart Disease Studies.

1988 • 127 citations

Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association.

1992 • 117 citations

Importance of Smoking for Chlamydia pneumoniae Seropositivity

1994 • 113 citations

Relation of Helicobacter pylori Infection to 13-Year Mortality and Incident Ischemic Heart Disease in the Caerphilly Prospective Heart Disease Study

1998 • 105 citations

Nail incorporation kinetics of terbinafine in onychomycosis patients

1995 • 101 citations

PREVALENCE, MORBIDITY, AND COST OF DERMATOLOGICAL DISEASES

1979 • 90 citations

Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses

1994 • 75 citations

Chlamydia pneumoniae and atherosclerosis--an update.

1997 • 64 citations

Significance of Non-Dermatophyte Moulds and Yeasts in Onychomycosis

1997 • 61 citations

Chlamydia pneumoniae antibodies and serum lipids in Finnish men: cross sectional study

1997 • 48 citations

Comparison of Chlamydia pneumoniae isolates by western blot (immunoblot) analysis and DNA sequencing of the omp 2 gene

1994 • 44 citations

Elevated Chlamydia pneumoniae Antibodies, Cardiovascular Events, and Azithromycin in Male Survivors of Myocardial Infarction

1998 • 38 citations

Oral antifungal agents for onychomycosis

1998 • 30 citations

Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study

1999 • 21 citations

Large-scale epidemiological study of the causal agents of onychomycosis: mycological findings from the Multicenter Onychomycosis Study of Terbinafine

1997 • 18 citations

Intermittent pulse therapy with itraconazole in onychomycosis: an update

1995 • 8 citations